Neuronetics, Inc. (STIM) NASDAQ
1.56
-0.11(-6.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Neuronetics, Inc.
Address
3222 Phoenixville Pike
Malvern, PA 19355
United States of America (the)
Phone
610 640 4202
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
716
First IPO Date
June 28, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Daniel L. Reuvers | President, Chief Executive Officer & Director | 927,610 | 1963 |
| Steven E. Pfanstiel | Executive Vice President, Treasurer & Chief Financial Officer | 557,223 | 1973 |
| W. Andrew Macan | EVice President, Chief Legal Officer & Corporate Secretary | 652,545 | 1973 |
| Francis X. Brown | Interim Principal Financial & Accounting Officer | 0 | N/A |
| Cory S. Anderson | SVP & Chief Technology Officer | 0 | N/A |
| Jeffrey S. Jones | Senior Vice President & Chief of Operations | 0 | 1956 |
| Lisa Metzner-Rosas | Senior Vice President & Chief Marketing Officer | 0 | N/A |
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
